These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8468433)

  • 21. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M; Nardi AE; Mundim FD; Alves AB
    J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
    Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ; Moritz E; Hellstern K; Malanowski H
    Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
    Beckers G; Vereecken A; de Bleeker E; Jaunes C; Sieben G; Faidherbe J; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():52-3. PubMed ID: 2248072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
    Evans L; George T; O'Sullivan B; Mitchell P; Johnson G; Adena M
    Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
    Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moclobemide (Ro 11-1163) safety in depressed patients.
    Moll E; Hetzel W
    Acta Psychiatr Scand Suppl; 1990; 360():69-70. PubMed ID: 2248078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
    Laux G; Beckmann H; Classen W; Becker T
    J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
    Casacchia M; Carolei A; Barba C; Frontoni M; Rossi A; Meco G; Zylberman MR
    Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
    Newburn GM; Fraser AR; Menkes DB; Mullen PE
    Aust N Z J Psychiatry; 1990 Dec; 24(4):475-9. PubMed ID: 2073222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression.
    Gabelic I; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():44-5. PubMed ID: 2248068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression.
    Gabelic I; Kuhn B
    Acta Psychiatr Scand Suppl; 1990; 360():63. PubMed ID: 2248076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressants, alcohol and psychomotor performance.
    Tiller JW
    Acta Psychiatr Scand Suppl; 1990; 360():13-7. PubMed ID: 2248062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
    Baumhackl U; Bizière K; Fischbach R; Geretsegger C; Hebenstreit G; Radmayr E; Stabl M
    Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
    Priest RG; Gimbrett R; Roberts M; Steinert J
    Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.
    Williams R; Edwards RA; Newburn GM; Mullen R; Menkes DB; Segkar C
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):155-8. PubMed ID: 8468437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
    Hebenstreit GF; Loidl M; Baumhackl U; Gallhofer B; Geretsegger C; Radmayr E; Saletu M; Schöny W; Stabl M
    J Neural Transm Suppl; 1990; 32():177-84. PubMed ID: 2089087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moclobemide: therapeutic use and clinical studies.
    Bonnet U
    CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.